Mice were treated with cotadutide, liraglutide, g1437 or liraglutide+g1437 at equimolar dosing (10 nmol/kg, SC, QD for 42 days) compared to vehicle
GLP-1 receptor agonists Glucagon-like Peptide 1 (GLP-1) and other GLP-1 receptor agonists have proven to be an effective treatment of Type 2 diabetes and obesity, offering significant benefits
With extended-release medicines, this can be the empty matrix after the drug has released
Froissard P, Monrocq H, Duval D
Best for: Systemic applications or multiple injury sites where broad distribution is desired Option C: Separated Sessions Sequence: BPC-157 in morning, cryotherapy in evening (or vice versa) Rationale: Eliminates potential interaction effects by separating the modalities entirely
If any metabolic markers worsen stop the supplement and check with your clinician